BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18095081)

  • 1. Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.
    Tamura S; Miki H; Nakata K; Takiuchi D; Okada K; Nakahira S; Okamura S; Sugimoto K; Tomita N; Takatsuka Y
    Gastric Cancer; 2007; 10(4):251-5. PubMed ID: 18095081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer.
    Tamura S; Miki H; Okada K; Miyake T; Yoshimura M; Suzuki R; Nakahira S; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Int J Clin Oncol; 2008 Dec; 13(6):536-40. PubMed ID: 19093182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of gastric cancer with peritoneal dissemination which showed the intraperitoneal CR by administrating TS-1 orally and paclitaxel intraperitoneally].
    Miki H; Tamura S; Wada H; Kozuma Y; Kittaka N; Kim T; Takiuchi D; Aihara T; Sugimoto K; Fukunaga M; Ozato H; Tomita N; Takatsuka Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1661-4. PubMed ID: 14619488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy].
    Asami S; Idani H; Kubo S; Sasaki H; Kurose Y; Nojima H; Yoshioka T; Muro M; Kumano K; Hirata M; Yamashita T; Kin H; Takakura N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2287-9. PubMed ID: 20037398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].
    Kadono M; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2442-4. PubMed ID: 21224600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer.
    Tamura S; Miki H; Okada K; Takeno A; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gastric Cancer; 2010 Jun; 13(2):101-8. PubMed ID: 20602197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
    Sasaki K; Natsugoe S; Aridome K; Ishigami S; Hokita S; Aikou T
    Hepatogastroenterology; 2007 Dec; 54(80):2421-4. PubMed ID: 18265679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis.
    Satoi S; Fujii T; Yanagimoto H; Motoi F; Kurata M; Takahara N; Yamada S; Yamamoto T; Mizuma M; Honda G; Isayama H; Unno M; Kodera Y; Ishigami H; Kon M
    Ann Surg; 2017 Feb; 265(2):397-401. PubMed ID: 28059968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
    Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated over 1 year 8 months with combined chemotherapy of paclitaxel and TS-1].
    Tamura S; Miki H; Nakata K; Kim C; Takiuchi D; Okada K; Okamura S; Aihara T; Sugimoto K; Ohzato H; Tomita N; Takatsuka Y
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):255-7. PubMed ID: 16484868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases.
    Shi M; Yang Z; Lu S; Liu W; Ni Z; Yao X; Hua Z; Feng R; Zheng Y; Wang Z; Sah BK; Chen M; Zhu Z; He C; Li C; Zhang J; Yan C; Yan M; Zhu Z
    BMC Cancer; 2021 Dec; 21(1):1344. PubMed ID: 34922478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Patient with Gastric Cancer with Peritoneal Dissemination Who Survived for Five Years after Sequential Chemotherapy with S-1 Followed by Paclitaxel].
    Urano S; Kakiuchi Y; Takashima H
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):251-4. PubMed ID: 27067693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
    Nakamura R; Saikawa Y; Kubota T; Nakamura T; Akatsu Y; Takahashi T; Yoshida M; Otani Y; Kumai K; Kitajima M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1323-6. PubMed ID: 16184933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of gastric cancer with peritoneal dissemination responding to combination chemotherapy with oral fluoropyrimidine and weekly paclitaxel].
    Tokunaga Y; Sasaki H; Saitou T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):999-1001. PubMed ID: 18633233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Long-Term Survival of a Patient with Gastric Cancer with Peritoneal Dissemination].
    Nakao K; Shitara K; Fukunari H; Yamamoto Y; Kato T; Okajima C; Hayashi T; Watanabe G
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2000-2. PubMed ID: 26805244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer: phase I study.
    Kurita N; Shimada M; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T; Nakao T
    J Med Invest; 2011 Feb; 58(1-2):134-9. PubMed ID: 21372498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial.
    Kodera Y; Takahashi N; Yoshikawa T; Takiguchi N; Fujitani K; Ito Y; Miyamoto K; Takayama O; Imano M; Kobayashi D; Miyashita Y; Morita S; Sakamoto J
    Gastric Cancer; 2017 Jan; 20(1):190-199. PubMed ID: 26879545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis.
    Imano M; Peng YF; Itoh T; Nishikawa M; Satou T; Yasuda A; Inoue K; Kato H; Shinkai M; Tsubaki M; Yasuda T; Imamoto H; Nishida S; Furukawa H; Takeyama Y; Okuno K; Shiozaki H
    Anticancer Res; 2012 Sep; 32(9):4071-5. PubMed ID: 22993363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.